A detailed history of Red Tortoise LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Red Tortoise LLC holds 163 shares of SAGE stock, worth $1,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
163
Holding current value
$1,137
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$10.58 - $17.9 $1,724 - $2,917
163 New
163 $1,000
Q3 2023

Nov 02, 2023

BUY
$16.75 - $48.98 $3,182 - $9,306
190 New
190 $3,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $415M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Red Tortoise LLC Portfolio

Follow Red Tortoise LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Tortoise LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Tortoise LLC with notifications on news.